in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 50,000 employees worldwide, the company...
of Shanchol® have been supplied worldwide through UNICEF-led vaccination campaigns. After production was paused under its former ownership, GCBC Vaccines Pvt. Ltd. (formerly Shantha) has resumed manufacturing, with WHO conducting an on-site...
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology,...
as Chief Medical Officer. A physician-scientist with more than 15 years of experience in diagnostics and emerging platforms, Dr. Vucetic has directed medical and scientific strategies that move technologies from discovery to clinical settings,...
enabling long-term modulation of the classical and alternative pathways of the complement cascade. GA is an advanced form of dry AMD that leads to irreversible vision loss, with limited therapeutic options currently available. "FDA clearance of the...
Despite the transformative potential of Artificial Intelligence, a pervasive 'AI anxiety' is holding back a significant portion of the biopharma industry, a worry that is directly linked to the need for a clear return on investment, according to...
journey, the LEQEMBI Companion app was developed with Medisafe, a digital patient engagement and medication management platform. From educational information about the injection process to a tool for tracking where and when injections occur, the...
of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, please visit www.caredx.com.
effective and efficient. With Niagen, we are equipping our franchisees and serving our guests with the very best.” Outperforming NAD+ IV in a pilot clinical study, Niagen IV offers superior tolerability, a 75% shorter infusion time (30-45 minute...
CSU across many countries, including in the European Union, Japan, and China, with priority review granted in China. Transforming care in Immunology "This approval of Rhapsido as the first and only BTK inhibitor in CSU is an important milestone in...
integrating contouring precision, structural support, and tissue regeneration into a single treatment. CollPlant's formulation combines hyaluronic acid with a modified form of rhCollagen to deliver both immediate and long-lasting benefits....
heart failure, and hepatic and renal disease, including nephrotic syndrome in adults. INDICATION AND IMPORTANT SAFETY INFORMATION FOR ENBUMYST™ (BUMETANIDE NASAL SPRAY). INDICATION: ENBUMYST is indicated for the treatment of edema associated with...
or the regimen of 10 mg/kg once every two weeks may be continued. AD is a progressive, relentless disease characterized by formation of protein deposits known as plaques made of amyloid-beta aggregates and neurofibrillary tangles made of tau...
with heart failure with left ventricular ejection fraction (HF LVEF) ≥40% (10mg, 20mg, 40mg tablets) IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS: Hypersensitivity to any component of this product Concomitant use with strong CYP3A4 inhibitors...
improve patients' quality of life. By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. For more information, please visit www.bora-corp.com.
long-acting therapeutic proteins and next-generation ADCs, developed by its proprietary NexP™-fusion and NexMab™ platform technology, respectively. It also developed a proprietary recombinant human hyaluronidase enzyme utilizing Hybrozyme™...
development, and potential therapeutic targets prior to intervention. Sanguine leverages its integrated technology platform to streamline data and donor engagement. By securely importing electronic medical records (EMRs) directly from clinic...
has been shown to increase branching of dendrites and synaptic plasticity signals.10 Indication and Important Safety Information for DAYBUE® (trofinetide) Indication DAYBUE is indicated for the treatment of Rett syndrome in adults and pediatric...
balanced between cohorts: median age was 65 years (range, 22-86); 66% male, 34% female; 96% of patients had an ECOG performance status of 0-1. PD-L1 expression data were collected from 83% of patients (69 of 83 patients) enrolled at U.S. sites and...
FORTE basket study, which includes BRAF V600 altered thyroid cancers, as we aim to generate further data to inform treatment and help patients with BRAF driven tumors.” The results presented at ATA 2025 are from 21 patients with thyroid cancer, 16...
